High efficacy is accompanied with substantial gains in patient reported outcomes in cirrhotic patients with chronic hepatitis C treated with sofosbuvir (SOF), velpatasvir with or without voxilaprevir (VOX): data from POLARIS 1, 2, 3 and 4

2017 ◽  
Vol 66 (1) ◽  
pp. S114 ◽  
Author(s):  
Z.M. Younossi ◽  
M. Stepanova ◽  
I. Jacobson ◽  
S. Zeuzem ◽  
M. Bourliere ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Patient Reported Outcomes ◽  
High Efficacy ◽  
Patient Reported ◽  
Cirrhotic Patients

The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study

2015 ◽  
Vol 36 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Zobair M. Younossi ◽  
Maria Stepanova ◽  
Stanislas Pol ◽  
Jean-Pierre Bronowicki ◽  
Maria Patrizia Carrieri ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Patient Reported Outcomes ◽  
Patient Reported ◽  
Cirrhotic Patients ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document